[EN] PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 4 DE LA PROSTAGLANDINE E2 ET LEURS UTILISATIONS
申请人:TEON THERAPEUTICS INC
公开号:WO2020251957A1
公开(公告)日:2020-12-17
Disclosed herein are compounds, compositions, and methods for modulating the prostaglandin E2 receptor 4 (EP4) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or disorders that are mediated by the action of prostaglandin E2 (PGE2) at the prostaglandin E2 receptor 4 (EP4), such as cancer, with EP4 antagonists.
作者:Lijun Lu、Renyi Shi、Luyao Liu、Jingwen Yan、Fangling Lu、Aiwen Lei
DOI:10.1002/chem.201602791
日期:2016.10.4
compounds is an attractive prospect in organic synthesis. In particular, the combination of C(sp3)−H activation and oxidative carbonylation involving alkanes and CO gas is a promising and efficient method to synthesize carbonyl derivatives. However, due to the high C−H bond dissociation energy and low polarity of unactivated alkanes, the carbonylation of unactivated C(sp3)−H bonds still remains a great challenge